TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
CLDX

Celldex Therapeutics Inc

Healthcare · Biotechnology

31.10$ -7.1% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Celldex Therapeutics Inc (CLDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 782 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CLDX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
252 383 360 346 319 316 191 178 168 156 148 142 132 123 113 261 256 236 219 205 460 445 424 403 369 353 325 299 280 466 869 846 823 792 739 692 648 583 511 782
210 196 173 160 147 145 131 120 111 99 89 84 75 67 56 209 203 198 181 168 427 411 391 368 335 318 290 265 246 432 835 812 779 747 694 648 604 535 459 725
32 42 42 66 55 40 40 44 33 24 32 20 17 11 23 68 18 44 69 43 72 39 25 28 19 29 54 28 21 35 115 43 36 28 17 23 36 29 36 47
203 190 167 154 141 139 123 114 106 94 85 81 73 64 54 207 200 194 176 164 423 408 380 357 323 305 278 253 235 422 824 802 756 725 673 630 583 519 451 718
1.6 1.8 1.4 1.4 3.0 1.9 4.0 3.4 3.2 3.2 2.3 1.2 0.7 1.2 1.1 0.3 0.8 1.8 1.8 0.5 0.2 0.2 0.2 0.1 0.2 0.3 1.3 0.1 0.3 4.5 2.7 1.5 0.9 0.7 1.1 0.1 0.1 2.0 0.2 0.2
-1.6 -1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 -3.2 – 0.0 0.0 -1.0 – 0.0 0.0 -1.8 0.0 – – -0.2 0.0 0.0 0.0 -0.3 -1.3 -0.1 0.0 0.0 0.0 – – – – – – – – –
11 13 12 12 11 10 9.8 7.5 6.7 6.1 5.5 5.1 4.5 4.0 4.1 4.0 3.8 7.3 3.7 6.2 3.3 6.5 3.5 7.7 3.8 7.7 4.0 3.9 – – – – – – – – – – – –
9.0 91 91 91 91 91 91 0.0 0.0 – – – – – – – – – – – – – – – – – – 3.4 – – – – – – – – – – – –
20 81 81 81 68 68 49 49 49 51 49 49 49 49 49 45 45 31 31 31 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27
35 118 112 115 100 79 57 50 40 32 35 33 30 29 29 23 26 26 25 22 23 25 26 38 24 27 22 22 34 36 30 32 37 45 36 37 50 56 55 68
19 35 27 29 25 28 24 20 17 13 12 12 12 12 11 11 12 14 17 14 14 17 15 30 16 19 15 16 28 31 26 28 32 40 32 33 46 51 51 61
4.4 4.8 4.9 5.5 5.8 6.6 6.6 – 4.7 4.5 2.6 2.5 2.3 1.9 1.7 1.3 1.3 1.3 1.4 1.3 1.4 1.7 1.8 1.4 1.4 1.4 1.5 1.5 1.5 1.6 1.6 1.6 1.4 1.5 1.5 1.5 1.6 1.6 1.5 1.6
1.0 1.7 2.7 2.0 1.3 1.7 0.5 2.9 2.3 1.1 1.1 1.0 0.7 1.2 1.6 1.0 0.6 1.0 1.0 0.7 0.8 1.2 1.0 0.9 2.3 3.3 3.4 0.9 3.6 3.5 3.2 3.8 1.1 3.3 3.4 2.1 4.3 1.2 10 15
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 2.6 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
217 265 248 231 219 236 134 128 128 124 113 110 101 94 84 238 230 209 194 182 437 419 398 365 345 326 303 278 247 429 839 814 786 747 703 655 598 527 456 715
-687 -719 -754 -782 -809 -813 -929 -946 -953 -962 -980 -991 -1,003 -1,013 -1,026 -1,037 -1,051 -1,073 -1,090 -1,103 -1,123 -1,144 -1,167 -1,203 -1,229 -1,256 -1,285 -1,316 -1,354 -1,397 -1,430 -1,466 -1,508 -1,555 -1,609 -1,666 -1,733 -1,814 -1,893 -1,966
6.7 7.2 8.2 8.3 8.6 9.4 9.4 9.8 11 12 12 14 15 16 17 22 39 40 40 40 45 47 47 47 47 47 47 47 47 52 59 66 66 66 66 66 66 67 67 78

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?